Compare ADIL & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADIL | CHNR |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.3M |
| IPO Year | 2017 | 1996 |
| Metric | ADIL | CHNR |
|---|---|---|
| Price | $2.28 | $4.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | ★ 189.8K | 25.4K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.50 |
| 52 Week High | $3.67 | $57.47 |
| Indicator | ADIL | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 67.55 | 46.69 |
| Support Level | $1.59 | $3.92 |
| Resistance Level | $3.67 | $4.25 |
| Average True Range (ATR) | 0.22 | 0.25 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 82.41 | 15.23 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.